NCT00216411View on ClinicalTrials.gov

Effects on Quality of Life Following Dysport Treatment in Post-stroke Spasticity of the Arm

PHASE4CompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

July 20, 2006

Study Completion Date

July 20, 2006

Conditions
Cerebrovascular AccidentMuscle Spasticity
Interventions
BIOLOGICAL

Botulinum toxin type A

DRUG

Placebo

Trial Locations (6)

2031

Prince of Wales Hospital, Randwick

2050

Royal Prince Alfred Hospital, Camperdown

2144

St Josephs Hospital, Auburn

3084

Austin Health, Heidelberg

3128

Box Hill Hospital, Box Hill

3162

Caulfield General Medical Centre, Caulfield

Sponsors

Lead Sponsor

Ipsen
All Listed Sponsors
lead

Ipsen

INDUSTRY